XLO logo

Xilio Therapeutics (XLO) Cash From Investing

Annual CFI

-$486.00 K
+$1.38 M+73.97%

December 31, 2023


Summary


Performance

XLO Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherXLOcash flowmetrics:

Quarterly CFI

-$9000.00
+$12.00 K+57.14%

September 30, 2024


Summary


Performance

XLO Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherXLOcash flowmetrics:

TTM CFI

-$30.00 K
-$9000.00-42.86%

September 30, 2024


Summary


Performance

XLO TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherXLOcash flowmetrics:

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

XLO Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+74.0%0.0%0.0%
3 y3 years+77.8%0.0%0.0%
5 y5 years-0.0%0.0%

XLO Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+74.0%<-9999.0%+98.8%-42.9%+98.4%
5 y5-yearat high+77.8%<-9999.0%+98.8%-42.9%+98.4%
alltimeall timeat high+77.8%<-9999.0%+98.8%-42.9%+98.4%

Xilio Therapeutics Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
-$9000.00(-57.1%)
-$30.00 K(+42.9%)
Jun 2024
-
-$21.00 K(<-9900.0%)
-$21.00 K(-93.4%)
Mar 2024
-
$0.00(0.0%)
-$316.00 K(-35.0%)
Dec 2023
-$486.00 K(-74.0%)
$0.00(0.0%)
-$486.00 K(-51.2%)
Sep 2023
-
$0.00(-100.0%)
-$995.00 K(-25.1%)
Jun 2023
-
-$316.00 K(+85.9%)
-$1.33 M(-25.5%)
Mar 2023
-
-$170.00 K(-66.6%)
-$1.78 M(-4.5%)
Dec 2022
-$1.87 M
-$509.00 K(+52.9%)
-$1.87 M(+7.5%)
DateAnnualQuarterlyTTM
Sep 2022
-
-$333.00 K(-56.8%)
-$1.74 M(+14.4%)
Jun 2022
-
-$771.00 K(+203.5%)
-$1.52 M(+28.1%)
Mar 2022
-
-$254.00 K(-32.8%)
-$1.18 M(+7.6%)
Dec 2021
-$1.10 M(-49.7%)
-$378.00 K(+231.6%)
-$1.10 M(+52.4%)
Sep 2021
-
-$114.00 K(-74.0%)
-$722.00 K(+18.8%)
Jun 2021
-
-$438.00 K(+157.6%)
-$608.00 K(+257.6%)
Mar 2021
-
-$170.00 K
-$170.00 K
Dec 2020
-$2.19 M(+206.0%)
-
-
Dec 2019
-$715.00 K
-
-

FAQ

  • What is Xilio Therapeutics annual cash flow from investing activities?
  • What is the all time high annual CFI for Xilio Therapeutics?
  • What is Xilio Therapeutics annual CFI year-on-year change?
  • What is Xilio Therapeutics quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Xilio Therapeutics?
  • What is Xilio Therapeutics quarterly CFI year-on-year change?
  • What is Xilio Therapeutics TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Xilio Therapeutics?
  • What is Xilio Therapeutics TTM CFI year-on-year change?

What is Xilio Therapeutics annual cash flow from investing activities?

The current annual CFI of XLO is -$486.00 K

What is the all time high annual CFI for Xilio Therapeutics?

Xilio Therapeutics all-time high annual cash flow from investing activities is -$486.00 K

What is Xilio Therapeutics annual CFI year-on-year change?

Over the past year, XLO annual cash flow from investing activities has changed by +$1.38 M (+73.97%)

What is Xilio Therapeutics quarterly cash flow from investing activities?

The current quarterly CFI of XLO is -$9000.00

What is the all time high quarterly CFI for Xilio Therapeutics?

Xilio Therapeutics all-time high quarterly cash flow from investing activities is $0.00

What is Xilio Therapeutics quarterly CFI year-on-year change?

Over the past year, XLO quarterly cash flow from investing activities has changed by $0.00 (0.00%)

What is Xilio Therapeutics TTM cash flow from investing activities?

The current TTM CFI of XLO is -$30.00 K

What is the all time high TTM CFI for Xilio Therapeutics?

Xilio Therapeutics all-time high TTM cash flow from investing activities is -$21.00 K

What is Xilio Therapeutics TTM CFI year-on-year change?

Over the past year, XLO TTM cash flow from investing activities has changed by $0.00 (0.00%)